Skip to content
Screener

Willis Towers Watson WTW Share-based Goods and Nonemployee Services Transaction, Modification of Terms, Incremental Compensation Cost

Share-based Goods and Nonemployee Services Transaction, Modification of Terms, Incremental Compensation Cost at other companies

Willis Towers Watson logo
Willis Towers WatsonWTW
$3.5M0.0%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$2.85M
Rackspace Technology, Inc. logo
Rackspace Technology, Inc.RXT
$25K
ACR
ACRES Commercial RealtyACR
$540K-33.7%
TDS
Telephone and Data SystemsTDS
$124.03M+6.6%
Carriage Services logo
Carriage ServicesCSV
$23.9M+0.5%

Other financials

Income statement

See full
Revenue$2.5B+9.1%
Operating income$364.0M-1.1%
Net income$229.0M-30.8%
EPS (diluted)$2.43-26.8%

Balance sheet

See full
Cash & equivalents$1.6B-17.1%
Total debt$7.1B+19.6%
Total equity$7.7B-5.1%
Total assets$30.6B+7.3%

Cash flow

See full
Operating cash flow$484.0M+34.1%
CapEx$59.0M+1.7%
Free cash flow$425.0M+40.3%

Valuation

See full
Market cap$31.86B-0.8%
Enterprise value$37.33B+3.5%
P/E20.4×
P/S3.2×-0.1×

Profitability

See full
Operating margin22.2%+12.7pp
Net margin15.5%
FCF margin16.7%+4.7pp

Returns & leverage

See full
Return on equity19.8%
Debt / equity0.9×+0.2×
Current ratio1.1×0.0×

Where this comes from

Reported directly by Willis Towers Watson in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost.

The source filing: Willis Towers Watson’s 10-K, filed February 25, 2025.

Filed
Feb 25, 2025
Fiscal year
FY2024
Accession
0000950170-25-026278

During the year ended December 31, 2023, certain performance-based RSU awards were modified to either better align the payout percentages for the broad-based population with the awards granted to the executive officers, or to reflect the impact of the divestment of our Russian business (see Note 3 — Acquisitions and Divestitures for additional information). In total, 464 grantees benefited from the modifications. Incremental compensation cost of $14 million is being recognized over the remaining service periods, $6 million of which is included within transaction and transformation on the consolidated statements of comprehensive income during the year ended December 31, 2023.

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

FAQ

What is Willis Towers Watson's share-based goods and nonemployee services transaction, modification of terms, incremental compensation cost?
Willis Towers Watson (WTW) reported share-based goods and nonemployee services transaction, modification of terms, incremental compensation cost of $3.5M in Q4 2024.
How has Willis Towers Watson's share-based goods and nonemployee services transaction, modification of terms, incremental compensation cost changed year-over-year?
Willis Towers Watson's share-based goods and nonemployee services transaction, modification of terms, incremental compensation cost decreased by 0.0% year-over-year, from $3.5M to $3.5M.
What does share-based goods and nonemployee services transaction, modification of terms, incremental compensation cost mean?
This represents the incremental compensation cost recognized due to modifications of share-based payment awards. When terms are changed, the company must often recognize additional expense if the fair value of the award increases. This metric highlights the financial cost of adjusting employee incentive programs.

Ask your AI about Willis Towers Watson's share-based goods and nonemployee services transaction, modification of terms, incremental compensation cost.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude